Published • loading... • Updated
US FDA Approves Wockhardt’s Zaynich for Complicated UTI Treatment in Adults
Summary by The CSR Journal
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
US FDA Approves Wockhardt’s Zaynich for Complicated UTI Treatment in Adults
The US Food and Drug Administration (FDA) has approved Wockhardt’s antibiotic, Zaynich, for treating complicated urinary tract infections (cUTIs) in adults. This decision was announced by the company on Thursday and is significant as it addresses infections caused by designated susceptible microorganisms. Zaynich is a combination of Zidebactam and Cefepime, aimed at treating severe conditions, including kidney infections known as pyelonephritis.…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
